Allergan Announces Completion of Inamed Acquisition - Research and Markets Offers a Brief of 'Allergan' Conference Call.DUBLIN, Ireland -- The Allergan (NYSE NYSE See: New York Stock Exchange :AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) Corporate Conference Call took place on 27-Mar-06 11:00am ET. AGN forecasted total sales for 2006 in a range of $2,805-2,945m. For full-year 2006, the Co. expects adjusted diluted EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. to be $3.56-3.62. For 1Q06, sales are estimated to be $600-610m and diluted EPS on an adjusted basis is expected to be $0.80-0.81. The $1.6b cash component required to purchase Inamed has been addressed with $500m of cash from the Co.s balance sheet and approx. $1.1b from the bridge refinancing Refinancing An extension and/or increase in amount of existing debt. it had put into place. More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/83540 This document provides a non-biased summary of the conference call detailing the key points and the full Q&A session. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion